Hepatocyte growth factor/c-met signaling in head and neck cancer and implications for treatment

HIGHLIGHTS

• who: Natalie J. Rothenberger and Laura P. Stabile from the Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA have published the research work: Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment, in the Journal: (JOURNAL)
• what: This study reported a nearly 40% increase in the HGF serum levels of R/M HNSCC patients compared to healthy controls and 23% increase in nonrecurrent patients compared with controls .
• future: Xenograft models continue to provide an effective means for identifying inhibitors for further clinical development . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.